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PUMP-DOWNLOADED INSULIN USAGE FOR THE FIRST 12 MONTHS IN A 
COHORT OF CHILDREN NEWLY-DIAGNOSED WITH TYPE 1 DIABETES (T1D). 
Ridyard CH1, Blair J2, Hughes DA1, on behalf of the SCIPI Trial Investigators .3 
1Bangor University, Bangor, United Kingdom, 2Alder Hey Children's NHS Foundation Trust, Liverpool, United 
Kingdom, 3Clinical Trials Research Centre, Liverpool, United Kingdom 
OBJECTIVES: Continuous subcutaneous insulin infusions (CSII) are an alternative to multiple daily injections 
(MDI) for glycaemic control and reducing risks of developing long term microvascular and macrovascular 
complications in type 1 diabetes (T1D). As part of a randomised clinical trial (SCIPI, ISRCTN29255275), we 
compared insulin usage downloaded from CSII pumps with General Practitioner (GP)-recorded insulin 
prescriptions given to a newly-diagnosed paediatric cohort. METHODS: Patients between 7 months and 15 years 
of age, newly diagnosed with T1D participated in this pragmatic, open, multicentre, parallel group, randomised, 
controlled trial. Total daily insulin usage (basal and bolus) recorded in the pumps from day 0 to day 365 was 
downloaded for patients initially randomised to CSII and analysed and compared to insulin usage recorded from 
their GP prescriptions. RESULTS: Pump data was available for 94/144 patients randomised to CSII (<5y: 21; 5 to 
<12y: 54; 12 to 15y: 19). Among these patients, data were available for a median of 198 days (range 28 to 343; 
mean 194). Mean prescribed insulin usage for these 94 patients was 70 U/day (95%CI: 58, 81) and compared 
well with the prescribed mean of 72 U/day (95%CI: 63, 82) for the whole 144-patient cohort. Mean recorded daily 
usage (min, max; 95%CI) for the three age groups was: (i) <5y: 12 U/day (2, 21; 9 to 14); (ii) 5 to <12y: 20 U/day 
(4, 36; 17 to 23); (iii) 12 to 15y: 37 U/day (9, 65; 32 to 42). CONCLUSIONS: Pump downloads provide an 
accurate record of insulin usage in paediatric populations with T1D. However, this study shows a large disparity 
between the quantities of insulin prescribed and insulin used. Reasons for this disparity might include: over-
prescription, prescriptions not being collected and physical losses (e.g. spillage and priming of pumps). This may 
have implications when estimating drug utilitsation costs. 
 
